NUVISION BIOTHERAPIES LIMITED

Active Nottingham

Manufacture of pharmaceutical preparations

26 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparations
N

NUVISION BIOTHERAPIES LIMITED

Manufacture of pharmaceutical preparations

Founded 7 Apr 2015 Active Nottingham, England 26 employees website.com
Life sciences and medical technology Manufacture of pharmaceutical preparations

Previous Company Names

NU VISION BIOTHERAPIES LIMITED 7 Apr 2015 — 8 Aug 2015
Accounts Submitted 9 Mar 2026 Next due 31 Mar 2026 3 months overdue
Confirmation Submitted 14 Apr 2026 Next due 25 Feb 2027 9 months remaining
Net assets £1M £1M 2025 year on year
Total assets £1M £1M 2025 year on year
Total Liabilities £360K £248K 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Medicity, D6 Building Thane Road Nottingham NG90 6BH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NUVISION BIOTHERAPIES LIMITED (09526225), an active life sciences and medical technology company based in Nottingham, England. Incorporated 7 Apr 2015. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type total-exemption-full
Next accounts 30 Jun 2025
Due by 31 Mar 2026 3 months overdue

Net Assets, Total Assets & Total Liabilities (2015–2025)

Cash in Bank

£928.80k

Increased by £884.51k (+1997%)

Net Assets

£1.08M

Increased by £1.26M (+709%)

Total Liabilities

£360.45k

Decreased by £247.57k (-41%)

Turnover

N/A

Employees

26

Increased by 5 (+24%)

Debt Ratio

25%

Decreased by 116 (-82%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5
Grants 2

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jul 2015Seed
Investor 2Feb 2018Unknown/Other
Investor 3Feb 2018Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 63,828 Shares £4.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Mar 20254,154£270k£65
18 Jul 20243,076£200k£65
10 Dec 20237,105£462k£65
3 Jan 202314,558£946k£65
1 Apr 202124,946£1.62m£65

Officers

Officers

1 active 2 resigned
Status
Hopkinson, Andrew, DrDirectorBritishEngland4920 May 2015Active

Shareholders

Shareholders (65)

Meif Proof Of Concept & Early Stage Lp
19.3%
27,860
Mercia Meifii
10.7%
15,384

Persons with Significant Control

Persons with Significant Control (4)

4 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent
Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent

Ugf Nominees Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

NUVISION BIOTHERAPIES LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026OfficersAppointment of Mr Noel Waters as director on 19 Jun 2025
14 Apr 2026Confirmation StatementConfirmation statement made on 11 Feb 2026 with updates
14 Apr 2026OfficersTermination of Noel Waters as director on 19 Jun 2025
7 Apr 2026OfficersTermination of Jonathan Mark Treherne as director on 31 Mar 2026
9 Mar 2026AccountsAnnual accounts made up to 30 Jun 2025
14 Apr 2026 Officers

Appointment of Mr Noel Waters as director on 19 Jun 2025

14 Apr 2026 Confirmation Statement

Confirmation statement made on 11 Feb 2026 with updates

14 Apr 2026 Officers

Termination of Noel Waters as director on 19 Jun 2025

7 Apr 2026 Officers

Termination of Jonathan Mark Treherne as director on 31 Mar 2026

9 Mar 2026 Accounts

Annual accounts made up to 30 Jun 2025

Recent Activity

Latest Activity

Appointment of Mr Noel Waters as director on 19 Jun 2025

1 months ago on 14 Apr 2026

Confirmation statement made on 11 Feb 2026 with updates

1 months ago on 14 Apr 2026

Termination of Noel Waters as director on 19 Jun 2025

1 months ago on 14 Apr 2026

Termination of Jonathan Mark Treherne as director on 31 Mar 2026

1 months ago on 7 Apr 2026

Annual accounts made up to 30 Jun 2025

2 months ago on 9 Mar 2026